vimarsana.com

Latest Breaking News On - Institutional trading of alnylam pharmaceuticals - Page 1 : vimarsana.com

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Receives $216 19 Average PT from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Given Average Recommendation of Moderate Buy by Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Receives $215 88 Consensus PT from Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year […]

Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by StockNews com to Buy

StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. A number of other research firms have also issued reports on ALNY. Morgan Stanley reduced their price target on shares of Alnylam Pharmaceuticals from $184.00 to $176.00 and set an […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.